Guidelines updated for use of perioperative β-blockade

December 2009
PharmacoEconomics & Outcomes News;12/12/2009, Issue 593, p3
The article reports on the changes made to the guidelines for the clinical application of perioperative Î’-blockade. The guidelines, which was developed by the American College of Cardiology Foundation/American Heart Association (ACCF/AHA), was updated to depict the developments in the use of Î’-adrenergic receptor antagonists prior to noncardiac surgery. Such changes include the recommended use of Î’-blockers in patients at risk of cardiac events and patients with coronary heart disease.


Related Articles

  • News in brief...  // PharmacoEconomics & Outcomes News;1/17/2004, Issue 444, p6 

    Discusses research being done on the use of beta-blocker in patients with chronic heart failure. Reference to a study by R. Gupta et al, published in the January 2004 issue of the "American Heart Journal"; Percentage of the patients who were receiving beta-blocker; Age range of the patients.

  • Effect of Beta-blockade and ACE Inhibition on B-type Natriuretic Peptides in Stable Patients with Systolic Heart Failure. Jens Rosenberg; Finn Gustafsson; Willem Remme; Günter Riegger; Per Hildebrandt // Cardiovascular Drugs & Therapy;Aug2008, Vol. 22 Issue 4, p305 

    Abstract Introduction  The long-term effect of beta-blockade on the plasma levels of natriuretic peptides BNP and its N-terminal counterpart, NT-proBNP, as risk markers in heart failure (HF) is obscure. Methods  Stable systolic HF patients from the CARMEN study...

  • Study of beta blocker in post-MI bracydardia or heart block.  // Cardiovascular Devices & Drugs;Mar2008, Vol. 14 Issue 3, p24 

    The article reports on the plan of Feinberg School of Medicine at Northwestern University in Evanston, Illinois to conduct a study that will investigate whether a pacemaker-enabled administration of beta-blockers in patients with post-myocardial infarction bradycardia or heart block will also...

  • Beta-blockers in heart failure. Newson, Louise // GP: General Practitioner;2/2/2007, p45 

    The article focuses on the use of beta-blockers in heart failure (HF). The author thinks that HF is a common but poorly managed condition. In the Cardiac Insufficiency Bisoprolol Trial II, the Carvedilol Prospective Randomised Cumulative Survival Study (COPERNICUS) and the Metoprolol Randomised...

  • β-Blocker use should be restricted.  // Reactions Weekly;Nov2014, Vol. 1529 Issue 1, p6 

    An abstract of the article "Usefulness of Beta Blockade in Contemporary Management of Patients With Stable Coronary Heart Disease," by D. E. Winchester and colleagues is presented.

  • Most needy miss out on Î’-blockers.  // Pulse;10/4/2004, Vol. 64 Issue 39, p7 

    Reports that patients who would benefit most from beta blockers are least often receiving them in Great Britain. Conditions prevented by beta blockers.

  • Antiarrhythmic Action of β-Blockers: Potential Mechanisms. Dorian, Paul // Journal of Cardiovascular Pharmacology & Therapeutics;Jun2005 Supplement, Vol. 10 Issue 2S, pS15 

    The article reports that multiple direct and indirect mechanisms of adrenergic action on the heart may benefit from the known antiarrhythmic actions of β-blocker therapy and other interventions that decrease sympathetic tone. The blockers in the heart are responsible for the primary direct...

  • Beta-blockers: Beyond cardiology. Daroff, Robert B.; Frishman, William H.; Lederman, Richard J.; Stewart, William C.; Millard, William B. // Patient Care;6/15/1993, Vol. 27 Issue 11, p47 

    Discusses the non-cardiologic uses of beta-blockers. List of beta-blockers approved for glaucoma; Complications of topical beta-blockers in the central nervous system; Factors considered in the administration of beta-blockers for migraine.

  • Does β-blocker prophylaxis improve survival after major noncardiac surgery? Terblanche, Marius; Adhikari, Neill K. J.; Scales, Damon C. // CMAJ: Canadian Medical Association Journal;10/11/2005, Vol. 173 Issue 8, p874 

    Presents a study on the relation of β-blockade therapy and the risk of death after major noncardiac surgery. Number of study participants; Limitations of the study; Implications of the study.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics